SCHEMBL22185229

SCHEMBL22185229

CCc1cc2cc(Cl)cc(OC)c2[nH]c1=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDH1 O75874 11/20 0.57
GSK3B P49841 2/20 0.41
CDK4 P11802 1/20 0.41
CCND1 P24385 1/20 0.41
PDE3B Q13370 1/20 0.40
PDE3A Q14432 1/20 0.40
TP53 P04637 1/20 0.40
THRB P10828 1/20 0.40
ALDH1A1 P00352 4/20 0.40
KDM4E B2RXH2 1/20 0.39
PLK4 O00444 1/20 0.39
CHEK1 O14757 1/20 0.39
AURKA O14965 1/20 0.39
NTRK1 P04629 1/20 0.39
LCK P06239 1/20 0.39
CDK1 P06493 1/20 0.39
CSF1R P07333 1/20 0.39
PIM1 P11309 1/20 0.39
RPS6KB1 P23443 1/20 0.39
CDK2 P24941 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17603389 0.88 IDH1 (0.55) IDH1TP53THRBALDH1A1KDM4E
SCHEMBL17603543 0.88 IDH1 (0.55) IDH1PDE3BPDE3ATP53THRB
SCHEMBL22185397 0.83 IDH1 (0.43) IDH1KDM4E
SCHEMBL22198974 0.81 IDH1 (0.47) IDH1GSK3BCDK4CCND1PDE3B
SCHEMBL22184948 0.81 ALDH1A1 (0.44) IDH1PDE3BPDE3ATP53THRB
SCHEMBL17603348 0.79 ERN1 (0.50) IDH1PDE3BPDE3AALDH1A1KDM4E
SCHEMBL22185228 0.78 HRH4 (0.43) IDH1ALDH1A1KDM4EHSD17B10
SCHEMBL22184887 0.78 IDH1 (0.45) IDH1PDE3BPDE3A
SCHEMBL17603509 0.77 ALDH1A1 (0.51) IDH1PDE3BPDE3AALDH1A1KDM4E
SCHEMBL20559286 0.77 CNR2 (0.53) IDH1ALDH1A1KDM4ELCKDYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200206233-A1 HETEROCYCLIC COMPOUNDS AS MUTANT IDH INHIBITORS INTEGRAL BIOSCIENCES PRIVATE LIMITED (IN) 2020-07-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200206233-A1 HETEROCYCLIC COMPOUNDS AS MUTANT IDH INHIBITORS IDH1, IDH2, IDH3A IDH1 1/4885GSK3B 558/4885CDK4 470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.